rs2166207
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001845.6(COL4A1):c.615+59T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.361 in 1,550,788 control chromosomes in the GnomAD database, including 104,323 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.40 ( 12663 hom., cov: 32)
Exomes 𝑓: 0.36 ( 91660 hom. )
Consequence
COL4A1
NM_001845.6 intron
NM_001845.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.934
Publications
8 publications found
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
- brain small vessel disease 1 with or without ocular anomaliesInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
- autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
- microangiopathy and leukoencephalopathy, pontine, autosomal dominantInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- familial porencephalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- pontine autosomal dominant microangiopathy with leukoencephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinal arterial tortuosityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 13-110209921-A-C is Benign according to our data. Variant chr13-110209921-A-C is described in ClinVar as Benign. ClinVar VariationId is 1272047.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.487 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.400 AC: 60740AN: 151962Hom.: 12633 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
60740
AN:
151962
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.374 AC: 93290AN: 249314 AF XY: 0.365 show subpopulations
GnomAD2 exomes
AF:
AC:
93290
AN:
249314
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.357 AC: 499675AN: 1398708Hom.: 91660 Cov.: 23 AF XY: 0.355 AC XY: 248490AN XY: 699872 show subpopulations
GnomAD4 exome
AF:
AC:
499675
AN:
1398708
Hom.:
Cov.:
23
AF XY:
AC XY:
248490
AN XY:
699872
show subpopulations
African (AFR)
AF:
AC:
16429
AN:
32258
American (AMR)
AF:
AC:
22274
AN:
44644
Ashkenazi Jewish (ASJ)
AF:
AC:
7608
AN:
25764
East Asian (EAS)
AF:
AC:
8981
AN:
39448
South Asian (SAS)
AF:
AC:
26813
AN:
84992
European-Finnish (FIN)
AF:
AC:
20993
AN:
53318
Middle Eastern (MID)
AF:
AC:
1879
AN:
5664
European-Non Finnish (NFE)
AF:
AC:
374090
AN:
1054346
Other (OTH)
AF:
AC:
20608
AN:
58274
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
15959
31919
47878
63838
79797
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
11706
23412
35118
46824
58530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.400 AC: 60829AN: 152080Hom.: 12663 Cov.: 32 AF XY: 0.399 AC XY: 29669AN XY: 74342 show subpopulations
GnomAD4 genome
AF:
AC:
60829
AN:
152080
Hom.:
Cov.:
32
AF XY:
AC XY:
29669
AN XY:
74342
show subpopulations
African (AFR)
AF:
AC:
20443
AN:
41482
American (AMR)
AF:
AC:
6864
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
1045
AN:
3466
East Asian (EAS)
AF:
AC:
1257
AN:
5170
South Asian (SAS)
AF:
AC:
1448
AN:
4818
European-Finnish (FIN)
AF:
AC:
4135
AN:
10596
Middle Eastern (MID)
AF:
AC:
107
AN:
292
European-Non Finnish (NFE)
AF:
AC:
24645
AN:
67956
Other (OTH)
AF:
AC:
770
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1847
3694
5540
7387
9234
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
566
1132
1698
2264
2830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1087
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.